| A Study of QL1706 in Combination With Bevacizumab and/or Chemotherapy as First-line Treatment in Patients With Advanced Hepatocellular Carcinoma (NCT05976568) | Qilu Pharmaceutical Co., Ltd. | 2023-09-01 |
| Clearance of Asymptomatic Pharyngeal Carriage of Neisseria Gonorrhoeae With or Without Ceftriaxone Treatment: Randomized Non-inferiority Study (NCT05971550) | Assistance Publique - Hôpitaux de Paris | 2023-09-01 |
| Evaluation of Using Dienogest and N-Acetyl Cysteine on the Volume of Uterine Leiomyoma (NCT06115408) | Ain Shams University | 2023-09-01 |
| Intensive Postpartum Antihypertensive Treatment (NCT05687344) | Medical College of Wisconsin | 2023-09-01 |
| Sulfasalazine in Patients With Metastatic Colorectal Cancer (NCT06134388) | Tanta University | 2023-09-01 |
| Lenvatinib, Tislelizumab Combined with Gemcitabine and Cisplatin (GPLET) in the Treatment of Advanced Cholangiocarcinoma (NCT05823311) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2023-09-01 |
| Induction Chemoimmunotherapy for Patients With High-risk Neuroblastoma (NCT06071897) | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 2023-09-01 |
| PeRinatal Outcomes With ACTive Versus Expectant Management of Women With Pre-labor Rupture Of Membranes (NCT05958953) | University of Modena and Reggio Emilia | 2023-09-01 |
| Enhancing Work Participation of Unemployed and Work-Disabled Cancer Survivors (NCT06028048) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2023-09-01 |
| Envollizumab Combined With Fruquintinib and SOX Versus SOX for Conversion Therapy in Advanced Gastric Cancer (NCT05914610) | Fujian Medical University | 2023-09-01 |
| Radiotherapy Combined With Almonertinib for Stage III EGFR-Mutated Lung Cancer (NCT05994339) | Laibin People's Hospital | 2023-09-01 |
| Efficacy of Continuous Terlipressin Therapy After Endoscopic Variceal Ligation (NCT06027970) | Post Graduate Institute of Medical Education and Research, Chandigarh | 2023-09-01 |
| GNT Induction Treatment in Locally Advanced NPC (NCT06026878) | Air Force Military Medical University, China | 2023-09-01 |
| Combined Cerebrolysin and Amantadine Sulfate Administration for Patients With Traumatic Brain Injury in the ICU (NCT06052787) | Ain Shams University | 2023-09-01 |
| Study of "Sputnik Lite" for the Prevention of COVID-19 With Altered Antigenic Composition. (NCT06057025) | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | 2023-09-01 |
| A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis (NCT06016842) | Ipsen | 2023-08-31 |
| A Study of Olverembatinib in Patients With Newly Diagnosed Ph+ ALL (POLARIS-1) (NCT06051409) | Ascentage Pharma Group Inc. | 2023-08-31 |
| Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Non-Erosive Gastroesophageal Reflux Disease (NERD) (NCT06121830) | Daewoong Pharmaceutical Co. LTD. | 2023-08-31 |
| A Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy (nHCM) (NCT06081894) | Cytokinetics | 2023-08-31 |
| HELIOS: Open-Label, Long-Term Extension Study to Investigate the Safety, Tolerability, and Efficacy of DISC-1459 (Bitopertin) in Participants With EPP or XLP (NCT05883748) | Disc Medicine, Inc | 2023-08-31 |
| A Study of an Intermittent ADT Approach With Apalutamide Monotherapy in Participants With mCSPC (NCT05884398) | Janssen Research & Development, LLC | 2023-08-31 |
| A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations (NCT06052267) | Teva Branded Pharmaceutical Products R&D LLC | 2023-08-30 |
| Effect of PRP, PPP, & BMAC on Functional Outcomes Following Hip Arthroscopy for Acetabular Labral Pathologies (NCT06003101) | Massachusetts General Hospital | 2023-08-30 |
| The Evaluation of the Effectiveness and Safety of Nalbuphine Hydrochloride Injection for Analgesia in ICU Patients: A Multicenter, Randomized, Single-blinded, Parallel, Two-step Trial (NCT06785571) | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2023-08-30 |
| Mifepristone and Misoprostol for Undesired Pregnancy of Unknown Location (NCT05839899) | Planned Parenthood League of Massachusetts | 2023-08-30 |
| Long-term Follow-up Study to Evaluate Safety and Immunogenicity of CHIKV VLP Single or Booster Vaccination (NCT06007183) | Bavarian Nordic | 2023-08-30 |
| Pediatric Patients Aged 1 to 6 Years With APDS (NCT05693129) | Pharming Technologies B.V. | 2023-08-30 |
| XG005 for Pain Control in Subjects Undergoing Bunionectomy (NCT06017999) | Xgene Pharmaceutical Group | 2023-08-29 |
| The Present Study Aims to Compare Patients Who Receive the Investigational Product (177Lu-DOTA-rosopatamab) Plus Standard of Care, in Comparison to Standard of Care Only (NCT04876651) | Telix Pharmaceuticals (Innovations) Pty Ltd | 2023-08-29 |
| To Compare the Efficacy and Safety of Oral SHR 7280 Tablets With Ganirelix Acetate Injection in Infertile Female Subjects (NCT05994378) | Jiangsu HengRui Medicine Co., Ltd. | 2023-08-29 |
| A Phase 3 Clinical Trials for Bowel Preparation for Colonoscopy (NCT06287606) | Taejoon Pharmaceutical Co., Ltd. | 2023-08-29 |
| Cellulitis Optimal Antibiotic Treatment (NCT05584007) | University of Southampton | 2023-08-29 |
| A Study to Evaluate the Efficacy and Safety of AST-001 in ASD Children (NCT06333964) | Astrogen, Inc. | 2023-08-29 |
| A Clinical Study to Evaluate the Efficacy and Safety of Subcutaneous JS005 Injection in the Treatment of Adults With Moderate to Severe Chronic Plaque Psoriasis (NCT05975268) | Shanghai Junshi Bioscience Co., Ltd. | 2023-08-28 |
| Nicotinamide Chemoprevention for Keratinocyte Carcinoma in Solid Organ Transplant Recipients - Pivotal Trial (NCT05955924) | Women's College Hospital | 2023-08-28 |
| Efficacy of Mirabegron for Treatment of Non-monosymptomatic Nocturnal Enuresis in Children (NCT07398261) | Menoufia University | 2023-08-28 |
| A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-2) (NCT06126224) | Karuna Therapeutics, Inc., a Bristol Myers Squibb company | 2023-08-28 |
| Parallel Arm Trial of AD109 and Placebo With Patients With OSA (LunAIRo) (NCT05811247) | Apnimed | 2023-08-28 |
| A Study of Daridorexant in Chinese Patients With Insomnia Disorder (NCT06010693) | Jiangsu Simcere Pharmaceutical Co., Ltd. | 2023-08-28 |
| Evaluation of the Non-Inferiority of a 12-Valent Pneumococcal Conjugate Vaccine in Healthy Children in Brazil. (NCT05721456) | Maria de Lourdes de Sousa Maia, MD | 2023-08-28 |
| A 32-week Trial to Evaluate the Efficacy and Safety of Tralokinumab in Subjects With Moderate-to-severe Atopic Hand Eczema Who Are Candidates for Systemic Therapy (NCT05958407) | LEO Pharma | 2023-08-28 |
| Injection of Botulinum Toxin for Thumb Carpometacarpal Arthritis (NCT05990881) | Rhode Island Hospital | 2023-08-27 |
| Effect of Hebal and Synthetic Medicamentss on Enterococcus Feacalis (NCT06006663) | Tanta University | 2023-08-26 |
| Effectiveness and Safety of Topical Hyaluronic Acid of Different Molecular Weights in Xerotic Skin Treatment (NCT06178367) | Indonesia University | 2023-08-26 |
| Perioperative Treatment With Tranexamic Acid in Melanoma (NCT05899465) | University of Aarhus | 2023-08-25 |
| The Efficacy and Safety of KN046 Combined With Axitinib (NCT06020352) | Shanghai Pulmonary Hospital, Shanghai, China | 2023-08-25 |
| A Multicenter, Randomized, Double-blind, Three-arm, Parallel Clinical Endpoint Bioequivalence Study of Monometasone Furoate Nasal Spray in Patients With Seasonal Allergic Rhinitis (NCT06200766) | Zheng Liu ENT | 2023-08-25 |
| A Phase 2/3 Trial to Assess the Efficacy and Safety of OCU410ST for Stargardt Disease (NCT05956626) | Ocugen | 2023-08-25 |
| Comparison of Ipratropium / Levosalbutamol Fixed Dose Combination and Ipratropium and Levosalbutamol Free Dose Combination Nebuliser Solutions in Stable Chronic Obstructive Pulmonary Disease (COPD) Patients (NCT05890638) | Neutec Ar-Ge San ve Tic A.Ş | 2023-08-25 |
| Study of Guselkumab Versus Placebo for the Treatment of Low Body Surface Area Moderate Plaque Psoriasis (NCT06039189) | Janssen Research & Development, LLC | 2023-08-24 |
| A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma (NCT06023589) | AstraZeneca | 2023-08-24 |
| Effectiveness of Probiotics in Patients of Mild to Moderate Rheumatoid Arthritis (NCT06594822) | King Edward Medical University | 2023-08-24 |
| Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or Lymphoma (NCT05602194) | Children's Oncology Group | 2023-08-24 |
| Effect of Concentrated Growth Factors on Short Implant-Supported Overdentures (NCT06880965) | Tanta University | 2023-08-24 |
| Role of Octreotide in Non Variceal Bleeding (NCT06062719) | National Hepatology & Tropical Medicine Research Institute | 2023-08-23 |
| Mobile & Online-Based Interventions to Lessen Pain (NCT05152134) | Stanford University | 2023-08-23 |
| Efficacy and Safety of Olokizumab in Patients With Progressive Fibrosing Interstitial Lung Diseases (NCT06440746) | R-Pharm International, LLC | 2023-08-23 |
| A Study to Evaluate the Efficacy, Safety, and Drug Levels of Oral Ozanimod in Pediatric Participants With Moderately to Severely Active Crohn's Disease With an Inadequate Response to Conventional Therapy (NCT05470985) | Bristol-Myers Squibb | 2023-08-22 |
| ATSN-201 Gene Therapy in RS1-Associated X-linked Retinoschisis (NCT05878860) | Atsena Therapeutics Inc. | 2023-08-22 |
| Efficacy and Safety of Infliximab for Immune Checkpoint Inhibitor Induced Colitis (NCT05947669) | Odense University Hospital | 2023-08-22 |
| Candesartan Cilexetil + Chlorthalidone + Amlodipine Versus Exforge HCT®️ for Systemic Arterial Hypertension (NCT05920005) | Hospital Israelita Albert Einstein | 2023-08-22 |
| Next Generation ORS: Comparing ORS With Calcium vs Standard ORS in Reducing Severity of Acute Watery Diarrhea (NCT05814042) | University of Florida | 2023-08-21 |
| Artificial Tears to Prevent Nasolacrimal Duct Obstruction in Patients Treated With Radioactive Iodine for Thyroid Cancer (NCT05999630) | Vanderbilt University Medical Center | 2023-08-21 |
| A Study of Tirzepatide (LY3298176) in Chinese Participants With Type 2 Diabetes (SURPASS-CN-MONO) (NCT05963022) | Eli Lilly and Company | 2023-08-21 |
| Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cholangitis (NCT06174402) | Han Ying | 2023-08-21 |
| First-line Cryoablation for Early Treatment of Persistent Atrial Fibrillation (NCT05939076) | Region Örebro County | 2023-08-21 |
| A Study to Evaluate the Efficacy and Safety of LZM012 (NCT06110676) | Livzon Pharmaceutical Group Inc. | 2023-08-21 |
| Maximal Tumor Eradication for Oligometastatic Prostate Cancer (NCT06972511) | RenJi Hospital | 2023-08-20 |
| Vitamin C to Chemotherapy Related Anemia in Pancreatic Cancer (NCT06018883) | Fudan University | 2023-08-20 |
| A Study of Camrelizumab Plus Chemotherapy in Combination With or Without Famitinib as Neoadjuvant Therapy in Participants With Triple Negative Breast Cancer (BCTOP-T-N01) (NCT05999149) | Fudan University | 2023-08-20 |
| Elimination of Odor and Treatment of Malodorous Recalcitrant Wounds by Using Supraz and PRP-FG Versus Standard of Care (NCT05983302) | Mashhad University of Medical Sciences | 2023-08-20 |
| Clinical Study to Evaluate the Possible Efficacy of Nifuroxazide in Patient With Ulcerative Colitis (NCT05988528) | Mostafa Bahaa | 2023-08-20 |
| Activation of Autophagy and Suppression of Apoptosis by Dapagliflozin Attenuates Inflammatory Bowel Disease (NCT05986136) | Mostafa Bahaa | 2023-08-20 |
| A Phase 3 Clinical Study of QLM3004 in Delaying Myopia in Children (NCT06151587) | Qilu Pharmaceutical Co., Ltd. | 2023-08-20 |
| Pharmacogenomics IND Commercial SNP Clinical Study - Abiraterone and Single Nucleotide Polymorphisms (NCT03348670) | Han Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator, IRB Chair | 2023-08-18 |
| A Trial to Treat Polyomavirus Infections (BKPyV) in Kidney and Simultaneous Kidney Pancreas Transplant Recipients (NCT05325008) | The University of Queensland | 2023-08-18 |
| Outcome Study of Conventional Steroids Vs. Steroids Combined with Mycopehnolate in Newly Diagnosed Immune Thrombocytopenia Purpura. (NCT06288932) | National Institute of Blood and Marrow Transplant (NIBMT), Pakistan | 2023-08-18 |
| Immunogenicity and Safety Study of SCB-2023 Vaccine as a Booster in Adults (NCT05926440) | Clover Biopharmaceuticals AUS Pty | 2023-08-17 |
| AK112 in Combination With Chemotherapy in Advanced Squamous Non-Small Cell Lung Cancer (NCT05840016) | Akeso | 2023-08-17 |
| Randomized, Double-Blind, Placebo-Controlled Trial of REL-1017 as Adjunctive Treatment for MDD (NCT06011577) | Levomecor Inc. | 2023-08-17 |
| Normobaric Hyperoxia Combined With Intravenous Thrombolysis for Acute Ischemic Stroke (OPENS-3) (NCT05965687) | Ji Xunming,MD,PhD | 2023-08-17 |
| Normobaric Hyperoxia Combined With Intravenous Thrombolysis for Acute Ischemic Stroke：Longterm Outcome (OPENS-3L) (NCT05965193) | Ji Xunming,MD,PhD | 2023-08-17 |
| A Study to Evaluate the Efficacy and Safety of Clascoterone Solution in Treatment of Male Pattern Hair Loss (SCALP2) (NCT05914805) | Cassiopea SpA | 2023-08-17 |
| A Study to Evaluate Long-term Safety of Ecopipam Tablets in Children, Adolescents and Adults With Tourette's Disorder (NCT06021522) | Emalex Biosciences Inc. | 2023-08-16 |
| Best Antithrombotic Therapy in Patients With Acute Venous ThromboEmbolism While Taking Antiplatelets (NCT05627375) | Centre Hospitalier Universitaire de Saint Etienne | 2023-08-16 |
| Testing the Use of BRAF-Targeted Therapy After Surgery and Usual Chemotherapy for BRAF-Mutated Colon Cancer (NCT05710406) | Alliance for Clinical Trials in Oncology | 2023-08-16 |
| A Study to Learn How Gadoquatrane Moves Into, Through, and Out of the Body and How Safe it is in Children (From Birth to <18 Years), Who Will Undergo a Contrast Enhanced MRI (Quanti Pediatric) (NCT05915026) | Bayer | 2023-08-16 |
| A Study to Learn About the Safety and Immune Response of 20vPnC in Adults in India. (NCT05875727) | Pfizer | 2023-08-16 |
| Durvalumab With Chemotherapy as First Line Treatment in Patients With Advanced Biliary Tract Cancers (aBTCs) (NCT05771480) | AstraZeneca | 2023-08-16 |
| Phase 3 Adolescent Study for SARS-CoV-2 rS Variant Vaccines (NCT05973006) | Novavax | 2023-08-16 |
| Effect of L-Glutamine on Pulmonary Artery Pressure in Patients With Non-Transfusion-Dependent Thalassemia (NCT07210450) | Mazandaran University of Medical Sciences | 2023-08-15 |
| Study to Compare Efficacy Safety and Immunogenicity of ADL-018 With XOLAIR (Omalizumab) in Adults With Chronic Idiopathic Urticaria (NCT05774639) | Kashiv BioSciences, LLC | 2023-08-15 |
| Therapeutic Photobiomodulation and Tretament of Spasticity (NCT06536751) | University of Nove de Julho | 2023-08-15 |
| Double-blind Study to Evaluate the PK, Efficacy, Safety and Immunogenicity of MB12 Versus Keytruda® in Stage IV NSCLC (NCT05668650) | Laboratorio Elea Phoenix S.A. | 2023-08-15 |
| The Effect of N115 on Coughing in IPF Patients (NCT06037408) | Cellular Sciences, inc. | 2023-08-15 |
| A Research Study to See How Well CagriSema Helps People in China With Excess Body Weight Lose Weight (NCT05996848) | Novo Nordisk A/S | 2023-08-15 |
| REDEL Trial: Reduced Elective Nodal Dose for Anal Cancer Toxicity Mitigation (NCT05902533) | University of Cincinnati | 2023-08-14 |
| A Trial to Evaluate the Safety and Efficacy of Pulmonary Artery Denervation for the Treatment of Pulmonary Hypertension Associated With Left Heart Failure (NCT05824923) | Pulnovo Medical (Wuxi) Co., Ltd. | 2023-08-14 |
| A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis (NCT05862272) | Sumitomo Pharma Switzerland GmbH | 2023-08-14 |
| A Phase II/III Study of HR070803 in Combination With Oxaliplatin, 5-fluorouracil, Calcium Folinate and Bevacizumab Versus FOLFOX in Combination With Bevacizumab for First-line Treatment of Advanced Colorectal Cancer (NCT05945901) | Jiangsu HengRui Medicine Co., Ltd. | 2023-08-14 |